Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07694466Phase 1Not yet recruiting
Phase 1 trial of dronabinol (3 arms). Primary endpoints: Exhaled Breath Condensate at 180 minutes, Breath Volatile Organic Compound at 180 minutes and 1 more. Planned start Dec 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07694466.